Pay in 4 interest-free payments of $6.10 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Circulation 150 (1), A4136786
Levetiracetam is as effective as other agents (e.g., fosphenytoin or valproic acid), yet it has a superior safety profile and is very easy to use
Lower doses may be effective because of improved absorption More glutathione enters cells the undamaged, enhancing their ability to combat oxidative stress
The primary endpoint is change in DAS28-CRP at week 12, a validated measure of RA disease activity
Physiology Journals Baggio LL, Drucker DJ
US$ 26.77
US$ 29.39
US$ 21.73
US$ 23.04
US$ 20.50
US$ 23.30
US$ 20.06
